Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prokidney (PROK) Change in Accured Expenses: 2022-2025

Historic Change in Accured Expenses for Prokidney (PROK) over the last 4 years, with Sep 2025 value amounting to $51,000.

  • Prokidney's Change in Accured Expenses fell 99.11% to $51,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.6 million, marking a year-over-year decrease of 3.20%. This contributed to the annual value of $11.6 million for FY2024, which is 0.40% down from last year.
  • Prokidney's Change in Accured Expenses amounted to $51,000 in Q3 2025, which was up 102.29% from -$2.2 million recorded in Q2 2025.
  • In the past 5 years, Prokidney's Change in Accured Expenses ranged from a high of $13.0 million in Q2 2023 and a low of -$5.9 million during Q1 2024.
  • Moreover, its 3-year median value for Change in Accured Expenses was $51,000 (2025), whereas its average is $1.4 million.
  • Per our database at Business Quant, Prokidney's Change in Accured Expenses soared by 739.09% in 2023 and then tumbled by 2,238.46% in 2025.
  • Prokidney's Change in Accured Expenses (Quarterly) stood at $533,000 in 2022, then spiked by 625.14% to $3.9 million in 2023, then spiked by 202.87% to $11.7 million in 2024, then plummeted by 99.11% to $51,000 in 2025.
  • Its last three reported values are $51,000 in Q3 2025, -$2.2 million for Q2 2025, and -$5.9 million during Q1 2025.